1. Stocks
  2. Cyclerion Therapeutics Inc
  3. Swot
swot-logo

Cyclerion Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Cyclerion Therapeutics Inc has 20 Strengths, 4 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Increasing profits every quarter for the past four quarters

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Increasing profits every quarter for the past 4 quarters

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Volume Shockers

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Promoters increasing shareholding QoQ

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks